intersol

Generic: platelet additive 3

Labeler: fenwal, inc.
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name intersol
Generic Name platelet additive 3
Labeler fenwal, inc.
Dosage Form SOLUTION
Routes
INTRAVENOUS
Active Ingredients

sodium acetate 442 mg/100mL, sodium chloride 452 mg/100mL, sodium phosphate, dibasic, unspecified form 305 mg/100mL, sodium phosphate, monobasic, monohydrate 93 mg/100mL, trisodium citrate dihydrate 318 mg/100mL

Manufacturer
Fenwal, Inc.

Identifiers & Regulatory

Product NDC 0942-9605
Product ID 0942-9605_70787f82-c8d4-4714-af6b-bad3b6b93c87
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number BN080041
Listing Expiration 2026-12-31
Marketing Start 2025-04-14

Pharmacologic Class

Classes
acidifying activity [moa] anti-coagulant [epc] calcium chelating activity [moa] calculi dissolution agent [epc] decreased coagulation factor activity [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 09429605
Hyphenated Format 0942-9605

Supplemental Identifiers

UNII
4550K0SC9B 451W47IQ8X GR686LBA74 593YOG76RN B22547B95K

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name intersol (source: ndc)
Generic Name platelet additive 3 (source: ndc)
Application Number BN080041 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 442 mg/100mL
  • 452 mg/100mL
  • 305 mg/100mL
  • 93 mg/100mL
  • 318 mg/100mL
source: ndc
Packaging
  • 800 mL in 1 BAG (0942-9605-01)
source: ndc

Packages (1)

Ingredients (5)

sodium acetate (442 mg/100mL) sodium chloride (452 mg/100mL) sodium phosphate, dibasic, unspecified form (305 mg/100mL) sodium phosphate, monobasic, monohydrate (93 mg/100mL) trisodium citrate dihydrate (318 mg/100mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "70787f82-c8d4-4714-af6b-bad3b6b93c87", "openfda": {"unii": ["4550K0SC9B", "451W47IQ8X", "GR686LBA74", "593YOG76RN", "B22547B95K"], "spl_set_id": ["17dec820-1b57-4ac9-82a8-419cab664a2f"], "manufacturer_name": ["Fenwal, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "800 mL in 1 BAG (0942-9605-01)", "package_ndc": "0942-9605-01", "marketing_start_date": "20250414"}], "brand_name": "InterSol", "product_id": "0942-9605_70787f82-c8d4-4714-af6b-bad3b6b93c87", "dosage_form": "SOLUTION", "pharm_class": ["Acidifying Activity [MoA]", "Anti-coagulant [EPC]", "Calcium Chelating Activity [MoA]", "Calculi Dissolution Agent [EPC]", "Decreased Coagulation Factor Activity [PE]"], "product_ndc": "0942-9605", "generic_name": "Platelet Additive 3", "labeler_name": "Fenwal, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "InterSol", "active_ingredients": [{"name": "SODIUM ACETATE", "strength": "442 mg/100mL"}, {"name": "SODIUM CHLORIDE", "strength": "452 mg/100mL"}, {"name": "SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM", "strength": "305 mg/100mL"}, {"name": "SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE", "strength": "93 mg/100mL"}, {"name": "TRISODIUM CITRATE DIHYDRATE", "strength": "318 mg/100mL"}], "application_number": "BN080041", "marketing_category": "NDA", "marketing_start_date": "20250414", "listing_expiration_date": "20261231"}